spacer
home > ebr > summer 2019 > easy as adc
PUBLICATIONS
European Biopharmaceutical Review

Easy as ADC

Designed to deliver cytotoxic agents directly and specifically to diseased cells without damaging healthy tissue, antibodydrug conjugates (ADCs) bring the clinical benefits of improved efficacy and reduced toxicities when compared to conventional medicines and biological therapies. The emergence of fully automated, ultrasensitive, single cell screening technologies has brought new possibilities for the identification of novel antigen targets and ADCs. Such technological advances also offer the promise of greater efficiencies in drug design, development, and manufacture of these complex and costly therapies.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Xin Liu has over 15 years of R&D experience in the design and development of various microfluidic devices and systems for cell biology applications. Xin is the Head of Cell and Molecular Biology at Sphere Fluidics and is responsible for managing assay and application development for their flagship product, Cyto-Mine®. Before joining Sphere Fluidics, he spent two years as a post-doctoral Research Associate at the University of Cambridge, UK. Xin gained his PhD in analytical chemistry from the Chinese Academy of Sciences, China.
spacer
Dr Xin Liu
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Organization Updates

Philadelphia, PA – May 20, 2019 – PCI Pharma Services, a leading biopharmaceutical outsourcing services provider, is pleased to announce the following management updates to help drive the company’s future vision, strategy and growth.
More info >>

White Papers

R&D to Product: How to Reduce Costly Scale-Up Problems

Natoli Engineering Company, Inc.

When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect to process scaleup and performance of the formulation at production levels. Problems with capping/lamination and sticking/ picking are often first realized when a formulation is introduced to a level of compression required to supply market demand.
More info >>

 
Industry Events

World Vaccine Congress Europe

28-31 October 2019, Barcelona, Spain

The 20th annual World Vaccine Congress Europe is taking place 28-31 Oct in Barcelona. It’s the biggest and most established European vaccine event with over 250 speakers, 700+ senior vaccine attendees, hundreds of networking hours. It cover key topics across the complete vaccine value chain bringing together: • Government • big pharma • big biotech • SME Biotech • academia and the wider service provider community and their partners to discuss scientific, clinical and strategic advances and opportunities. The event has already confirmed over 200 speakers from Human Vaccine Project, OECD, CEPI, European Commission, FDA, WHO, OECD, NIH, GSK and many more… There is a Super Early Bird offer available – Find Out More www.terrapinn.com/WVCEU/EBR
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement